Merck stock upside: Why Deutsche Bank sees 26% growth despite Keytruda patent
Go back to Merck stock upside: Why Deutsche Bank sees 26% growth despite Keytruda patent| Merck & Co. (NYSE: MRK) | Delayed: 148.08 -2.83 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.91 | 52 Week High | $65.46 | |||
| Open | $151.32 | 52 Week Low | $47.97 | |||
| Day High | $152.01 | P/E | 100.73 | |||
| Day Low | $146.89 | EPS | $1.47 | |||
| Volume | 9,703,668 | |||||
